BullishAgent BullishAgent
EDGAR Earnings Ratings Insiders Shorts
ETFs Screener
Sign in Register
Holdings (Monthly) Guide ↗

iShares Biotechnology ETF

· iShares Trust
Monthly Holdings $8.9B AUM 196 positions Period Mar 2026 Filed May 28, 2026 EDGAR ↗ ← All Funds
All 54 New 196 Added 31 Exited · Mar 2026 vs Sep 2025
# Name Ticker Since Shares Shares Δ Value Val Δ% % Port Cat
1 BlackRock Funds III 066922519 Mar 2026 784,655,767 +1,928,164 $784.8M +0.2% 9.66% STIV
2 Gilead Sciences, Inc. 375558103 Mar 2026 4,515,707 +492,782 $629.4M +40.9% 7.75% EC
3 Amgen, Inc. 031162100 Mar 2026 1,733,148 +153,460 $609.8M +36.8% 7.51% EC
4 Vertex Pharmaceuticals, Inc. 92532F100 Mar 2026 1,354,033 +191,398 $604.6M +32.8% 7.44% EC
5 Regeneron Pharmaceuticals, Inc. 75886F107 Mar 2026 758,232 +156,065 $585.8M +73.0% 7.21% EC
6 Alnylam Pharmaceuticals, Inc. 02043Q107 Mar 2026 979,642 +239,530 $324.1M -4.0% 3.99% EC
7 Insmed, Inc. 457669307 Mar 2026 1,587,887 +369,063 $259.7M +47.9% 3.20% EC
8 Argenx SE 04016X101 Mar 2026 341,883 +88,168 $249.7M +33.4% 3.07% EC
9 Biogen, Inc. 09062X103 Mar 2026 1,091,046 +228,193 $200.0M +65.5% 2.46% EC
10 Natera, Inc. 632307104 Mar 2026 980,622 +200,465 $196.1M +56.2% 2.41% EC
11 United Therapeutics Corp. 91307C102 Mar 2026 315,509 +57,570 $187.1M +73.0% 2.30% EC
12 BeOne Medicines Ltd. 07725L102 Mar 2026 529,143 +161,733 $157.1M +25.5% 1.93% EC
13 Incyte Corp. 45337C102 Mar 2026 1,467,923 +330,295 $138.2M +43.2% 1.70% EC
14 Moderna, Inc. 60770K107 Mar 2026 2,692,459 +666,773 $136.8M +161.4% 1.68% EC
15 Illumina, Inc. 452327109 Mar 2026 1,107,291 +226,312 $136.5M +63.1% 1.68% EC
16 Revolution Medicines, Inc. 76155X100 Mar 2026 1,283,912 +328,618 $124.9M +179.9% 1.54% EC
17 Roivant Sciences Ltd. N/A Mar 2026 3,642,557 +2,694,909 $100.9M +254.9% 1.24% EC
18 Neurocrine Biosciences, Inc. 64125C109 Mar 2026 727,502 +158,564 $95.8M +20.0% 1.18% EC
19 Genmab A/S 372303206 Mar 2026 3,555,098 +884,567 $95.4M +16.5% 1.17% EC
20 Bridgebio Pharma, Inc. 10806X102 Mar 2026 1,238,687 +282,546 $92.0M +85.2% 1.13% EC
21 Ionis Pharmaceuticals, Inc. 462222100 Mar 2026 1,205,549 +273,434 $90.5M +48.5% 1.11% EC
22 Medpace Holdings, Inc. 58506Q109 Mar 2026 169,922 +36,145 $81.6M +18.6% 1.00% EC
23 Madrigal Pharmaceuticals, Inc. 558868105 Mar 2026 155,341 +36,454 $81.3M +49.1% 1.00% EC
24 Exelixis, Inc. 30161Q104 Mar 2026 1,871,326 +334,547 $80.3M +26.5% 0.99% EC
25 BioMarin Pharmaceutical, Inc. 09061G101 Mar 2026 1,412,330 +297,157 $79.8M +32.1% 0.98% EC
26 Ascendis Pharma A/S 04351P101 Mar 2026 339,948 +87,969 $77.8M +55.2% 0.96% EC
27 Praxis Precision Medicines, Inc. 74006W207 Mar 2026 195,097 +78,539 $62.9M +917.5% 0.77% EC
28 Charles River Laboratories International, Inc. 159864107 Mar 2026 362,165 +75,233 $62.5M +39.2% 0.77% EC
29 Arrowhead Pharmaceuticals, Inc. 04280A100 Mar 2026 975,175 +218,405 $61.1M +134.3% 0.75% EC
30 Vaxcyte, Inc. 92243G108 Mar 2026 1,045,695 +305,975 $60.8M +128.1% 0.75% EC
31 Bio-Techne Corp. 09073M104 Mar 2026 1,151,950 +245,468 $60.2M +19.4% 0.74% EC
32 Cytokinetics, Inc. 23282W605 Mar 2026 896,972 +207,023 $59.1M +55.9% 0.73% EC
33 Halozyme Therapeutics, Inc. 40637H109 Mar 2026 868,502 +186,537 $56.1M +12.2% 0.69% EC
34 Axsome Therapeutics, Inc. 05464T104 Mar 2026 319,088 +76,401 $53.9M +83.0% 0.66% EC
35 BioNTech SE 09075V102 Mar 2026 599,506 +227,603 $53.3M +45.3% 0.66% EC
36 Krystal Biotech, Inc. 501147102 Mar 2026 188,966 +42,377 $48.8M +88.6% 0.60% EC
37 Protagonist Therapeutics, Inc. 74366E102 Mar 2026 447,047 +100,457 $47.1M +104.7% 0.58% EC
38 Repligen Corp. 759916109 Mar 2026 396,896 +83,327 $46.8M +11.6% 0.58% EC
39 Kymera Therapeutics, Inc. 501575104 Mar 2026 521,385 +174,201 $43.4M +121.0% 0.53% EC
40 Rhythm Pharmaceuticals, Inc. 76243J105 Mar 2026 474,539 +111,815 $41.3M +12.7% 0.51% EC
41 PTC Therapeutics, Inc. 69366J200 Mar 2026 593,152 +144,867 $40.4M +46.9% 0.50% EC
42 Cogent Biosciences, Inc. 19240Q201 Mar 2026 1,009,396 +345,734 $38.9M +307.7% 0.48% EC
43 Arcellx, Inc. 03940C100 Mar 2026 335,814 +91,943 $38.6M +92.6% 0.47% EC
44 Terns Pharmaceuticals, Inc. 880881107 Mar 2026 713,848 +305,389 $37.6M +1126.9% 0.46% EC
45 Nuvalent, Inc. 670703107 Mar 2026 355,481 +92,138 $36.4M +59.9% 0.45% EC
46 Mirum Pharmaceuticals, Inc. 604749101 Mar 2026 392,677 +153,038 $36.3M +106.5% 0.45% EC
47 Tempus AI, Inc. 88023B103 Mar 2026 773,906 +206,714 $35.0M -23.6% 0.43% EC
48 Xenon Pharmaceuticals, Inc. 98420N105 Mar 2026 598,390 +162,016 $34.8M +98.6% 0.43% EC
49 Amicus Therapeutics, Inc. 03152W109 Mar 2026 2,307,725 +534,693 $33.4M +138.8% 0.41% EC
50 Apellis Pharmaceuticals, Inc. 03753U106 Mar 2026 778,245 +163,376 $31.3M +125.0% 0.39% EC
51 Apogee Therapeutics, Inc. 03770N101 Mar 2026 353,520 +136,480 $29.8M +245.1% 0.37% EC
52 Scholar Rock Holding Corp. 80706P103 Mar 2026 593,730 +156,810 $29.2M +79.4% 0.36% EC
53 ACADIA Pharmaceuticals, Inc. 004225108 Mar 2026 1,251,241 +264,275 $27.9M +32.2% 0.34% EC
54 Bruker Corp. 116794108 Mar 2026 764,342 +157,409 $27.6M +40.0% 0.34% EC
55 Crinetics Pharmaceuticals, Inc. 22663K107 Mar 2026 726,428 +212,856 $26.4M +23.3% 0.32% EC
56 CG oncology, Inc. 156944100 Mar 2026 379,295 +102,737 $25.7M +130.4% 0.32% EC
57 Spyre Therapeutics, Inc. 00773J202 Mar 2026 478,909 +177,524 $24.2M +378.2% 0.30% EC
58 Erasca, Inc. 29479A108 Mar 2026 1,384,399 +435,673 $22.4M +983.0% 0.28% EC
59 Tarsus Pharmaceuticals, Inc. 87650L103 Mar 2026 297,522 +70,121 $20.9M +54.4% 0.26% EC
60 Twist Bioscience Corp. 90184D100 Mar 2026 436,795 +97,212 $20.8M +117.2% 0.26% EC
61 Centessa Pharmaceuticals plc 152309100 Mar 2026 520,762 +165,959 $20.7M +140.4% 0.25% EC
62 Ideaya Biosciences, Inc. 45166A102 Mar 2026 615,636 +140,159 $20.5M +58.6% 0.25% EC
63 Denali Therapeutics, Inc. 24823R105 Mar 2026 1,055,210 +309,336 $20.3M +87.1% 0.25% EC
64 Travere Therapeutics, Inc. 89422G107 Mar 2026 674,600 +162,993 $20.0M +63.9% 0.25% EC
65 ImmunityBio, Inc. 45256X103 Mar 2026 2,572,701 +2,011,290 $19.7M +1328.8% 0.24% EC
66 Arcutis Biotherapeutics, Inc. 03969K108 Mar 2026 814,779 +198,591 $19.2M +65.3% 0.24% EC
67 Veracyte, Inc. 92337F107 Mar 2026 579,343 +126,112 $18.7M +19.9% 0.23% EC
68 Structure Therapeutics, Inc. 86366E106 Mar 2026 381,676 +146,308 $18.4M +179.1% 0.23% EC
69 Edgewise Therapeutics, Inc. 28036F105 Mar 2026 572,192 +132,604 $18.0M +152.8% 0.22% EC
70 10X Genomics, Inc. 88025U109 Mar 2026 841,716 +190,578 $17.9M +134.8% 0.22% EC
71 Legend Biotech Corp. 52490G102 Mar 2026 983,928 +231,507 $17.8M -27.5% 0.22% EC
72 Vera Therapeutics, Inc. 92337R101 Mar 2026 419,778 +133,613 $16.9M +103.1% 0.21% EC
73 Dyne Therapeutics, Inc. 26818M108 Mar 2026 917,470 +271,040 $16.6M +103.4% 0.20% EC
74 Beam Therapeutics, Inc. 07373V105 Mar 2026 692,124 +154,035 $16.5M +26.3% 0.20% EC
75 BioCryst Pharmaceuticals, Inc. 09058V103 Mar 2026 1,715,826 +520,640 $16.3M +80.1% 0.20% EC
76 Sarepta Therapeutics, Inc. 803607100 Mar 2026 739,607 +191,742 $16.1M +52.4% 0.20% EC
77 Immunovant, Inc. 45258J102 Mar 2026 626,211 +209,952 $15.6M +131.8% 0.19% EC
78 ADMA Biologics, Inc. 000899104 Mar 2026 1,711,239 +352,475 $15.4M -22.6% 0.19% EC
79 Adaptive Biotechnologies Corp. 00650F109 Mar 2026 1,105,997 +249,550 $15.4M +19.8% 0.19% EC
80 Summit Therapeutics, Inc. 86627T108 Mar 2026 799,477 +138,225 $15.2M +11.0% 0.19% EC
81 Oruka Therapeutics, Inc. 687604108 Mar 2026 304,331 +123,392 $14.9M +329.0% 0.18% EC
82 Syndax Pharmaceuticals, Inc. 87164F105 Mar 2026 631,524 +140,056 $14.8M +95.1% 0.18% EC
83 Tango Therapeutics, Inc. 87583X109 Mar 2026 687,885 +303,039 $14.4M +345.2% 0.18% EC
84 Ultragenyx Pharmaceutical, Inc. 90400D108 Mar 2026 680,286 +151,750 $14.3M -10.4% 0.18% EC
85 Disc Medicine, Inc. 254604101 Mar 2026 214,889 +79,464 $13.7M +53.5% 0.17% EC
86 Agios Pharmaceuticals, Inc. 00847X104 Mar 2026 400,087 +79,413 $13.5M +5.2% 0.17% EC
87 GRAIL, Inc. 384747101 Mar 2026 261,045 +84,904 $13.5M +29.5% 0.17% EC
88 Zymeworks, Inc. 98985Y108 Mar 2026 529,981 +99,818 $13.3M +80.6% 0.16% EC
89 Arcus Biosciences, Inc. 03969F109 Mar 2026 612,355 +226,556 $13.2M +152.1% 0.16% EC
90 BlackRock Funds III 066922477 Mar 2026 12,996,156 +1,865,974 $13.0M +16.8% 0.16% STIV
91 Aurinia Pharmaceuticals, Inc. 05156V102 Mar 2026 874,336 +173,978 $13.0M +67.4% 0.16% EC
92 Enliven Therapeutics, Inc. 29337E102 Mar 2026 322,556 +97,642 $12.6M +174.6% 0.16% EC
93 Day One Biopharmaceuticals, Inc. 23954D109 Mar 2026 578,773 +138,686 $12.4M +299.9% 0.15% EC
94 Vericel Corp. 92346J108 Mar 2026 373,502 +79,186 $12.0M +29.7% 0.15% EC
95 Mineralys Therapeutics, Inc. 603170101 Mar 2026 439,648 +188,451 $11.9M +25.0% 0.15% EC
96 Alumis, Inc. 022307102 Mar 2026 530,358 +136,492 $11.7M +643.5% 0.14% EC
97 Zai Lab Ltd. 98887Q104 Mar 2026 613,747 +158,245 $11.5M -25.2% 0.14% EC
98 Nurix Therapeutics, Inc. 67080M103 Mar 2026 720,848 +279,011 $11.2M +173.7% 0.14% EC
99 Stoke Therapeutics, Inc. 86150R107 Mar 2026 331,288 +60,509 $10.8M +69.5% 0.13% EC
100 Intellia Therapeutics, Inc. 45826J105 Mar 2026 835,337 +239,413 $10.7M +4.1% 0.13% EC
101 AnaptysBio, Inc. 032724106 Mar 2026 192,136 +41,248 $10.7M +130.6% 0.13% EC
102 Recursion Pharmaceuticals, Inc. 75629V104 Mar 2026 3,419,857 +1,456,251 $10.5M +9.6% 0.13% EC
103 Tyra Biosciences, Inc. 90240B106 Mar 2026 272,474 +75,596 $10.4M +278.9% 0.13% EC
104 Relay Therapeutics, Inc. 75943R102 Mar 2026 980,266 +212,887 $9.8M +143.5% 0.12% EC
105 Amylyx Pharmaceuticals, Inc. 03237H101 Mar 2026 687,536 +295,304 $9.6M +79.3% 0.12% EC
106 Novavax, Inc. 670002401 Mar 2026 1,157,114 +284,679 $9.4M +24.5% 0.12% EC
107 Iovance Biotherapeutics, Inc. 462260100 Mar 2026 2,619,021 +892,738 $9.2M +145.4% 0.11% EC
108 Immunocore Holdings plc 45258D105 Mar 2026 277,185 +69,042 $8.4M +10.5% 0.10% EC
109 Galapagos NV 36315X101 Mar 2026 271,893 +67,142 $8.2M +15.0% 0.10% EC
110 Grifols SA 398438408 Mar 2026 976,161 +260,751 $7.8M +9.9% 0.10% EC
111 Nuvation Bio, Inc. 67080N101 Mar 2026 1,795,888 +438,463 $7.7M +53.4% 0.09% EC
112 Taysha Gene Therapies, Inc. 877619106 Mar 2026 1,672,180 +365,284 $7.5M +74.9% 0.09% EC
113 Trevi Therapeutics, Inc. 89532M101 Mar 2026 608,481 +132,280 $7.3M +66.6% 0.09% EC
114 Mesoblast Ltd. 590717401 Mar 2026 460,143 +75,080 $7.1M +14.1% 0.09% EC
115 Corvus Pharmaceuticals, Inc. 221015100 Mar 2026 473,326 +147,124 $6.9M +188.0% 0.09% EC
116 Olema Pharmaceuticals, Inc. 68062P106 Mar 2026 457,751 +146,215 $6.8M +123.8% 0.08% EC
117 Rapport Therapeutics, Inc. 75383L102 Mar 2026 217,759 +114,792 $6.8M +122.8% 0.08% EC
118 Geron Corp. 374163103 Mar 2026 4,513,103 +949,653 $6.7M +37.7% 0.08% EC
119 Fortrea Holdings, Inc. 34965K107 Mar 2026 693,057 +160,366 $6.5M +45.6% 0.08% EC
120 Vir Biotechnology, Inc. 92764N102 Mar 2026 704,449 +176,192 $6.3M +109.3% 0.08% EC
121 Xencor, Inc. 98401F105 Mar 2026 513,267 +118,251 $6.2M +33.6% 0.08% EC
122 AbCellera Biologics, Inc. 00288U106 Mar 2026 1,732,022 +402,852 $6.0M -9.6% 0.07% EC
123 CareDx, Inc. 14167L103 Mar 2026 337,886 +45,219 $5.9M +37.8% 0.07% EC
124 Monte Rosa Therapeutics, Inc. 61225M102 Mar 2026 346,430 +74,368 $5.7M +182.7% 0.07% EC
125 KalVista Pharmaceuticals, Inc. 483497103 Mar 2026 276,916 +56,092 $5.6M +107.3% 0.07% EC
126 Janux Therapeutics, Inc. 47103J105 Mar 2026 392,349 +73,384 $5.5M -30.0% 0.07% EC
127 MannKind Corp. 56400P706 Mar 2026 2,199,381 +442,447 $5.4M -42.9% 0.07% EC
128 ORIC Pharmaceuticals, Inc. 68622P109 Mar 2026 424,422 +94,873 $5.4M +36.0% 0.07% EC
129 Castle Biosciences, Inc. 14843C105 Mar 2026 215,689 +49,568 $5.3M +40.0% 0.07% EC
130 Annexon, Inc. 03589W102 Mar 2026 952,884 +391,819 $5.3M +208.5% 0.06% EC
131 Kura Oncology, Inc. 50127T109 Mar 2026 628,449 +132,190 $5.1M +16.3% 0.06% EC
132 Inhibrx Biosciences, Inc. 45720N103 Mar 2026 75,835 +17,678 $5.1M +160.3% 0.06% EC
133 Arbutus Biopharma Corp. 03879J100 Mar 2026 1,119,437 +242,128 $5.0M +26.5% 0.06% EC
134 ArriVent Biopharma, Inc. 04272N102 Mar 2026 201,242 +25,364 $4.6M +43.1% 0.06% EC
135 Cullinan Therapeutics, Inc. 230031106 Mar 2026 323,429 +103,790 $4.6M +252.9% 0.06% EC
136 Replimune Group, Inc. 76029N106 Mar 2026 570,930 +193,631 $4.4M +176.3% 0.05% EC
137 Precigen, Inc. 74017N105 Mar 2026 1,104,713 +234,422 $4.3M +49.3% 0.05% EC
138 Arvinas, Inc. 04335A105 Mar 2026 403,100 +24,178 $4.3M +32.4% 0.05% EC
139 Savara, Inc. 805111101 Mar 2026 775,563 +297,421 $4.2M +148.1% 0.05% EC
140 Ironwood Pharmaceuticals, Inc. 46333X108 Mar 2026 1,173,471 +251,556 $4.1M +241.0% 0.05% EC
141 Phathom Pharmaceuticals, Inc. 71722W107 Mar 2026 356,945 +132,820 $4.0M +50.3% 0.05% EC
142 Zevra Therapeutics, Inc. 488445206 Mar 2026 413,742 +86,577 $3.9M +23.9% 0.05% EC
143 Cytek Biosciences, Inc. 23285D109 Mar 2026 868,726 +187,560 $3.8M +60.6% 0.05% EC
144 ARS Pharmaceuticals, Inc. 82835W108 Mar 2026 463,404 +124,031 $3.7M +9.1% 0.05% EC
145 Sana Biotechnology, Inc. 799566104 Mar 2026 1,235,916 +383,395 $3.6M +17.6% 0.04% EC
146 Rigel Pharmaceuticals, Inc. 766559702 Mar 2026 131,031 +28,123 $3.5M +21.5% 0.04% EC
147 Compass Pathways plc 20451W101 Mar 2026 612,150 +235,040 $3.4M +56.7% 0.04% EC
148 OPKO Health, Inc. 68375N103 Mar 2026 2,882,600 +770,215 $3.3M +0.4% 0.04% EC
149 Solid Biosciences, Inc. 83422E204 Mar 2026 446,552 +100,535 $3.2M +50.6% 0.04% EC
150 4D Molecular Therapeutics, Inc. 35104E100 Mar 2026 338,744 +84,709 $3.2M +42.9% 0.04% EC
151 Emergent BioSolutions, Inc. 29089Q105 Mar 2026 376,503 +75,513 $3.1M +17.7% 0.04% EC
152 Myriad Genetics, Inc. 62855J104 Mar 2026 662,895 +141,963 $3.0M -20.8% 0.04% EC
153 Absci Corp. 00091E109 Mar 2026 975,088 +204,457 $2.9M +24.9% 0.04% EC
154 Perspective Therapeutics, Inc. 46489V302 Mar 2026 693,460 +335,293 $2.9M +135.4% 0.04% EC
155 Altimmune, Inc. 02155H200 Mar 2026 926,610 +423,158 $2.9M +50.4% 0.04% EC
156 Vanda Pharmaceuticals, Inc. 921659108 Mar 2026 405,038 +80,628 $2.8M +72.9% 0.03% EC
157 Allogene Therapeutics, Inc. 019770106 Mar 2026 1,145,572 +231,657 $2.8M +146.7% 0.03% EC
158 REGENXBIO, Inc. 75901B107 Mar 2026 331,423 +61,506 $2.8M +6.6% 0.03% EC
159 Rocket Pharmaceuticals, Inc. 77313F106 Mar 2026 752,567 +169,564 $2.7M +41.8% 0.03% EC
160 Pacific Biosciences of California, Inc. 69404D108 Mar 2026 2,021,533 +462,422 $2.7M +33.7% 0.03% EC
161 Lexeo Therapeutics, Inc. 52886X107 Mar 2026 457,447 +186,991 $2.6M +46.2% 0.03% EC
162 Enanta Pharmaceuticals, Inc. 29251M106 Mar 2026 205,184 +89,528 $2.6M +87.2% 0.03% EC
163 Standard BioTools, Inc. 34385P108 Mar 2026 2,747,556 +592,420 $2.5M -9.8% 0.03% EC
164 Design Therapeutics, Inc. 25056L103 Mar 2026 235,859 +52,200 $2.5M +81.5% 0.03% EC
165 Personalis, Inc. 71535D106 Mar 2026 393,153 +80,963 $2.5M +23.0% 0.03% EC
166 Atea Pharmaceuticals, Inc. 04683R106 Mar 2026 460,056 +80,920 $2.5M +125.1% 0.03% EC
167 Prime Medicine, Inc. 74168J101 Mar 2026 704,092 +147,403 $2.5M -20.6% 0.03% EC
168 Keros Therapeutics, Inc. 492327101 Mar 2026 214,789 +14,886 $2.4M -25.0% 0.03% EC
169 Fulgent Genetics, Inc. 359664109 Mar 2026 148,748 +32,402 $2.4M -10.1% 0.03% EC
170 Tectonic Therapeutic, Inc. 878972108 Mar 2026 75,889 +14,369 $2.3M +143.0% 0.03% EC
171 Aura Biosciences, Inc. 05153U107 Mar 2026 338,128 +93,190 $2.3M +49.4% 0.03% EC
172 Kyverna Therapeutics, Inc. 501976104 Mar 2026 251,263 +122,491 $2.2M +180.7% 0.03% EC
173 Maravai LifeSciences Holdings, Inc. 56600D107 Mar 2026 759,052 +149,573 $2.1M +22.8% 0.03% EC
174 Anavex Life Sciences Corp. 032797300 Mar 2026 668,447 +178,938 $2.1M -52.9% 0.03% EC
175 Entrada Therapeutics, Inc. 29384C108 Mar 2026 158,267 +21,061 $2.0M +151.0% 0.02% EC
176 Ginkgo Bioworks Holdings, Inc. 37611X209 Mar 2026 317,323 +78,444 $1.9M -44.1% 0.02% EC
177 Neurogene, Inc. 64135M105 Mar 2026 94,694 +22,201 $1.9M +52.0% 0.02% EC
178 LENZ Therapeutics, Inc. 52635N103 Mar 2026 206,971 +65,220 $1.9M -71.3% 0.02% EC
179 Autolus Therapeutics plc 05280R100 Mar 2026 1,321,681 +321,286 $1.8M +11.9% 0.02% EC
180 Editas Medicine, Inc. 28106W103 Mar 2026 731,163 +219,510 $1.8M +1.7% 0.02% EC
181 C4 Therapeutics, Inc. 12529R107 Mar 2026 608,839 +255,062 $1.6M +103.9% 0.02% EC
182 Larimar Therapeutics, Inc. 517125100 Mar 2026 350,415 +63,752 $1.6M +70.3% 0.02% EC
183 Arcturus Therapeutics Holdings, Inc. 03969T109 Mar 2026 186,967 +40,371 $1.4M -46.6% 0.02% EC
184 Voyager Therapeutics, Inc. 92915B106 Mar 2026 329,043 +64,987 $1.3M +3.0% 0.02% EC
185 Bicycle Therapeutics plc 088786108 Mar 2026 244,101 +60,583 $1.1M -20.3% 0.01% EC
186 Codexis, Inc. 192005106 Mar 2026 683,417 +188,506 $1.1M -7.8% 0.01% EC
187 Lyell Immunopharma, Inc. 55083R203 Mar 2026 54,413 +3,623 $1.1M +32.3% 0.01% EC
188 Foghorn Therapeutics, Inc. 344174107 Mar 2026 223,190 +46,893 $1.1M +23.8% 0.01% EC
189 Quanterix Corp. 74766Q101 Mar 2026 284,827 +53,360 $1.0M -20.2% 0.01% EC
190 Silence Therapeutics plc 82686Q101 Mar 2026 173,313 +140,776 $913K +440.9% 0.01% EC
191 Neumora Therapeutics, Inc. 640979100 Mar 2026 421,430 +13,311 $822K +10.6% 0.01% EC
192 PepGen, Inc. 713317105 Mar 2026 451,333 +274,004 $799K -2.5% 0.01% EC
193 Humacyte, Inc. 44486Q103 Mar 2026 1,222,120 +453,285 $741K -44.6% 0.01% EC
194 Pyxis Oncology, Inc. 747324101 Mar 2026 345,130 +89,826 $504K -11.1% 0.01% EC
195 Immutep Ltd. 45257L108 Mar 2026 809,244 +215,082 $284K -72.7% 0.00% EC
196 Alpha Teknova, Inc. 02080L102 Mar 2026 79,636 +11,537 $230K -45.4% 0.00% EC